Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7787]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Highlights from day one of the NCRI Cancer Conference 2013
Highlights from day one of the NCRI Cancer Conference 2013
Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs
Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs
Double-pronged attack could treat common children’s cancer
Double-pronged attack could treat common children’s cancer
Potential brain tumour drug can distinguish cancer cells from healthy ones
Potential brain tumour drug can distinguish cancer cells from healthy ones
Phase I/II clinical trial initiated with ISA101 in women with cervical cancer
Phase I/II clinical trial initiated with ISA101 in women with cervical cancer
A cost-effective way toward personalised cancer drugs
A cost-effective way toward personalised cancer drugs
WCLC 15: Latest in prevention, screening and treatment
WCLC 15: Latest in prevention, screening and treatment
Golden age of prostate cancer drug discovery and development as NICE draft guidance recommends new prostate cancer drug
Golden age of prostate cancer drug discovery and development as NICE draft guidance recommends new prostate cancer...
Scientists identify molecular switch that suppresses development of liver cancer
Scientists identify molecular switch that suppresses development of liver cancer
Two-drug combination, nab-paclitaxel and gemcitabine, improves survival in pancreatic cancer
Two-drug combination, nab-paclitaxel and gemcitabine, improves survival in pancreatic cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation